Ambrisentan for Early Low-Risk Pulmonary Arterial Hypertension
Clinical trial NCT06987097 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06987097
- Sponsor
- Nanjing First Hospital, Nanjing Medical University
- Status
- NOT_YET_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-15
- Primary completion
- 2028-02-28
- Enrollment
- 410
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.